Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darryl Falzarano

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|June 3, 2017
Assessment of Inhibition of Ebola Virus Progeny Production by Antiviral CompoundsDarryl Falzarano
The Lancet. Infectious Diseases|January 5, 2016
Ebola vaccines: we have optionsDarryl Falzarano
Current Opinion in Virology|June 19, 2013
Vaccines for viral hemorrhagic fevers--progress and shortcomingsDarryl Falzarano, Heinz Feldmann
Lancet (London, England)|March 31, 2015
An updated Ebola vaccine: immunogenic, but will it protect?Andrea Marzi, Darryl Falzarano
Cell Research|April 16, 2014
Possible leap ahead in filovirus therapeuticsDarryl Falzarano, Heinz Feldmann
Science (New York, N.Y.)|February 28, 2015
Virology. Delineating Ebola entryDarryl Falzarano, Heinz Feldmann
Science (New York, N.Y.)|November 24, 2022
The influenza universe in an mRNA vaccineAlyson A Kelvin, Darryl Falzarano
Molecular Immunology|March 22, 2021
Unique aspects of adaptive immunity in camelids and their applicationsSwarali S Kulkarni, Darryl Falzarano
The Journal of Infectious Diseases|May 8, 2015
Natural Immunity to Ebola Virus in the Syrian Hamster Requires Antibody ResponsesJoseph Prescott, Darryl Falzarano, Heinz Feldmann
Biotechniques|August 10, 2018
Caution: choice of fixative can influence the visualization of the location of a transcription factor in mammalian cellsArinjay Banerjee, Darryl Falzarano, Vikram Misra
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Methods in Molecular Biology (Clifton, N.J.)|June 3, 2017
Assessment of Inhibition of Ebola Virus Progeny Production by Antiviral CompoundsDarryl Falzarano
The Lancet. Infectious Diseases|January 5, 2016
Ebola vaccines: we have optionsDarryl Falzarano
Current Opinion in Virology|June 19, 2013
Vaccines for viral hemorrhagic fevers--progress and shortcomingsDarryl Falzarano, Heinz Feldmann
Lancet (London, England)|March 31, 2015
An updated Ebola vaccine: immunogenic, but will it protect?Andrea Marzi, Darryl Falzarano
Cell Research|April 16, 2014
Possible leap ahead in filovirus therapeuticsDarryl Falzarano, Heinz Feldmann
Science (New York, N.Y.)|February 28, 2015
Virology. Delineating Ebola entryDarryl Falzarano, Heinz Feldmann
Science (New York, N.Y.)|November 24, 2022
The influenza universe in an mRNA vaccineAlyson A Kelvin, Darryl Falzarano
Molecular Immunology|March 22, 2021
Unique aspects of adaptive immunity in camelids and their applicationsSwarali S Kulkarni, Darryl Falzarano
The Journal of Infectious Diseases|May 8, 2015
Natural Immunity to Ebola Virus in the Syrian Hamster Requires Antibody ResponsesJoseph Prescott, Darryl Falzarano, Heinz Feldmann
Biotechniques|August 10, 2018
Caution: choice of fixative can influence the visualization of the location of a transcription factor in mammalian cellsArinjay Banerjee, Darryl Falzarano, Vikram Misra
Pageof 10